Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Melatonin Acts as Antioxidant and Improves Sleep in MS Patients.
Nano- and micro-based systems for immunotolerance induction in Multiple Sclerosis.
Neurodegeneration: Active astrocytes drive inflammation.
Delayed nerve stimulation promotes axon-protective neurofilament phosphorylation, accelerates immune cell clearance and enhances remyelination in vivo in focally demyelinated nerves.
Natural Killer Cell Subsets in Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9.
Ipsilateral uveitis and optic neuritis in multiple sclerosis.
Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo.
How do autoimmune diseases cluster in families? A systematic review and meta-analysis.
Adaptive Immune Responses in CNS Autoimmune Disease: Mechanisms and Therapeutic Opportunities.
Multiple Sclerosis and the Iranian Revolution: Reply to the Comment by Magzhi et al..
Serum uric acid levels and their correlation with clinical and cerebrospinal fluid parameters in patients with neuromyelitis optica.
Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing-remitting multiple sclerosis in Sweden.
A case of multiple sclerosis and celiac disease.
The Gap in the Current Research on the Link between Health Locus of Control and Multiple Sclerosis: Lessons and Insights from a Systematic Review.
Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.
Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.
Pegylated interferons: a nurses' review of a novel multiple sclerosis therapy.
Cognitive motor interference during walking in multiple sclerosis using an alternate letter alphabet task.
Myelin damage and repair in pathologic CNS: challenges and prospects.
Myelin-specific T cells induce interleukin-1beta expression in lesion-reactive microglial-like cells in zones of axonal degeneration.
Country break-out session highlights.
Brain ageing and disorders of the central nervous system: kynurenines and drug metabolism.
Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
Pages
« first
‹ previous
…
415
416
417
418
419
420
421
422
423
…
next ›
last »